Q32 Bio (QTTB) Assets Average (2018 - 2026)

Q32 Bio's Assets Average history runs 9 years deep, the most recent figure standing at $62.7 million for Q1 2026.

• On a quarterly basis, Assets Average fell 26.81% year-over-year to $62.7 million in Q1 2026; TTM through Mar 2026 was $62.7 million, a 26.81% decrease from a year earlier, with the FY2025 full-year figure at $77.1 million, up 10.56% from the prior year.
• Assets Average climbed to $62.7 million in Q1 2026 per QTTB's latest filing, from $59.8 million in the prior quarter.
• Across five years, Assets Average topped out at $297.8 million in Q2 2022 and bottomed at $59.8 million in Q4 2025.
• The 5-year median for Assets Average is $114.4 million (2024), against an average of $148.1 million.
• Across the five-year window, Assets Average advanced 20.65% in 2022 and tumbled 61.9% in 2023, its largest moves.
• Year by year, Assets Average stood at $245.6 million in 2022, then tumbled by 61.9% to $93.6 million in 2023, then rose by 5.21% to $98.4 million in 2024, then tumbled by 39.27% to $59.8 million in 2025, then rose by 4.93% to $62.7 million in 2026.
• Per Business Quant, the three latest QTTB Assets Average figures stand at $62.7 million (Q1 2026), $59.8 million (Q4 2025), and $62.0 million (Q3 2025).